ISCA, CHRYSTEL
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.834
EU - Europa 2.057
AS - Asia 1.892
SA - Sud America 329
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 71
OC - Oceania 15
Totale 8.269
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.692
IT - Italia 762
SG - Singapore 491
CN - Cina 438
IE - Irlanda 254
GB - Regno Unito 249
BR - Brasile 227
VN - Vietnam 203
HK - Hong Kong 196
DE - Germania 176
BD - Bangladesh 162
SE - Svezia 153
FR - Francia 85
RU - Federazione Russa 80
IN - India 76
CA - Canada 72
FI - Finlandia 71
KR - Corea 52
ID - Indonesia 45
AR - Argentina 34
TR - Turchia 34
JP - Giappone 31
LT - Lituania 29
IQ - Iraq 27
EG - Egitto 26
NL - Olanda 26
MX - Messico 25
TW - Taiwan 23
CO - Colombia 22
UA - Ucraina 22
BG - Bulgaria 21
ES - Italia 19
BE - Belgio 18
MY - Malesia 18
PK - Pakistan 18
PL - Polonia 18
AU - Australia 15
CL - Cile 15
CZ - Repubblica Ceca 14
EC - Ecuador 13
ZA - Sudafrica 12
AE - Emirati Arabi Uniti 10
SA - Arabia Saudita 10
AT - Austria 9
MD - Moldavia 8
CR - Costa Rica 7
MA - Marocco 7
VE - Venezuela 7
HN - Honduras 6
JO - Giordania 6
KE - Kenya 6
NP - Nepal 6
PH - Filippine 6
SY - Repubblica araba siriana 6
GT - Guatemala 5
PE - Perù 5
PR - Porto Rico 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
CW - ???statistics.table.value.countryCode.CW??? 4
DZ - Algeria 4
EU - Europa 4
GP - Guadalupe 4
GR - Grecia 4
HR - Croazia 4
OM - Oman 4
PY - Paraguay 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EE - Estonia 3
ET - Etiopia 3
HU - Ungheria 3
KG - Kirghizistan 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
TH - Thailandia 3
BB - Barbados 2
CI - Costa d'Avorio 2
GA - Gabon 2
GH - Ghana 2
IL - Israele 2
IR - Iran 2
IS - Islanda 2
JM - Giamaica 2
KH - Cambogia 2
NI - Nicaragua 2
NO - Norvegia 2
QA - Qatar 2
SI - Slovenia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
Totale 8.196
Salva come PNG Salva come JPEG
Città #
Ashburn 573
Santa Clara 336
Singapore 279
San Jose 269
Chandler 255
Dublin 251
Hong Kong 188
Fairfield 179
Council Bluffs 158
Dallas 140
Beijing 108
Nyköping 99
Hefei 98
New York 92
Los Angeles 81
Houston 80
Southend 77
London 72
Milan 70
Woodbridge 67
Helsinki 64
Ann Arbor 63
Seattle 62
Ho Chi Minh City 58
Modena 58
Wilmington 50
Cambridge 48
Seoul 47
Bologna 45
The Dalles 45
Hanoi 40
Chicago 39
Dearborn 39
Rome 32
Jakarta 31
Munich 31
Fremont 29
Lauterbourg 28
Frankfurt am Main 27
Buffalo 26
Redwood City 26
Shanghai 26
Tokyo 24
Toronto 24
Moscow 23
Orem 23
San Diego 23
Sofia 21
São Paulo 21
Princeton 20
Baghdad 19
Asyut 18
Phoenix 18
Bremen 16
Jacksonville 16
Parma 16
Portsmouth 16
North Bergen 15
San Giuliano Milanese 15
Banqiao 14
Columbus 14
Mumbai 14
Reggio Emilia 14
Des Moines 13
Warsaw 13
Atlanta 12
Brooklyn 12
Brussels 12
Da Nang 12
Denver 12
Dong Ket 12
Haiphong 12
Lawrence 12
Madrid 12
Eugene 11
Nuremberg 11
Poplar 11
Sassuolo 11
Izmir 10
Mexico City 10
Montreal 10
Belo Horizonte 9
Brno 9
Castelvetrano 9
Düsseldorf 9
Guangzhou 9
Manchester 9
Paris 9
Absecon 8
Bari 8
Cardiff 8
Charlotte 8
Chennai 8
Chisinau 8
Genoa 8
Philadelphia 8
Redondo Beach 8
Schiffdorf 8
Springfield 8
Amsterdam 7
Totale 5.136
Salva come PNG Salva come JPEG
Nome #
Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients. 656
Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better? 481
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 419
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 404
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 390
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis 379
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 377
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 337
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 336
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 316
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 316
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 294
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era 294
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 289
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 282
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 275
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 272
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better? 270
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 269
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 262
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients. 260
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 240
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affectclinical outcome of metastatic breast cancer patients 227
Thyroid function impairment after chemo-immunotherapy for advanced NSCLC: A single institutional retrospective report 219
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes 190
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 178
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials. BMC Cancer 37
Totale 8.269
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022367 0 0 0 0 20 46 20 24 47 53 95 62
2022/2023978 79 121 58 82 80 79 16 70 300 29 32 32
2023/2024605 28 25 51 65 59 75 76 57 33 30 53 53
2024/20251.493 45 18 36 104 273 202 129 111 166 103 118 188
2025/20262.873 198 79 270 256 376 163 358 149 241 284 237 262
2026/2027778 97 147 225 282 27 0 0 0 0 0 0 0
Totale 8.269